Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

NCT03071809 is registered in ClinicalTrials.gov with Lexent Bio, Inc. as lead sponsor.

NCT NCT03071809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03071809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
Lead sponsor
Lexent Bio, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 30, 2017
Completion date
March 15, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, non-hematologic - stage i-iii